Prostate Cancer UK calls on UK to step up to cancer challenge

For the first time, more men are dying from prostate cancer each year than women are from breast cancer, making the male disease the third biggest cancer killer in the UK. Prostate Cancer UK is urging the public to ‘March for Men’ this summer to help curb the trend.

Prostate Cancer UKFigures released by Prostate Cancer UK reveal that 11,819 men now die from prostate cancer every year in the UK, compared to 11,442 women dying from breast cancer. It means the male-only disease is now the third most common cancer to die from, after lung and bowel cancer.

Since 1999, the number of women dying from breast cancer has been steadily decreasing, while prostate cancer deaths are still on the rise. During that time, breast cancer has benefited from a screening programme, significant investments in research and more than double the number of published studies compared to ones for prostate cancer.

Despite the alarming figures, the prospects for men with prostate cancer are actually better than ever, with men diagnosed today two-and-a-half times more likely to live for 10 years or more than if they were diagnosed in 1990. Yet due mainly to an increasing and ageing population, the number of men dying from the disease is growing.

Prostate Cancer UK Chief Executive, Angela Culhane, said: “It’s incredibly encouraging to see the tremendous progress that has been made in breast cancer over recent years. But with half the investment and half the research, it’s not surprising that progress in prostate cancer is lagging behind.

“The good news is that many of these developments could be applied to prostate cancer and we’re confident that with the right funding, we can dramatically reduce deaths within the next decade.”

Prostate Cancer UK believes that around £120 million of research needs to be funded over the next eight years to reverse the trend and achieve their 10-year goal to halve the number of expected prostate cancer deaths by 2026. And the charity is asking the public to help raise the vital funds needed by signing up for one of their March for Men walks this summer.

“Plans to create an accurate test fit for use as part of a nationwide prostate cancer screening programme, as well as developing new treatments for advanced prostate cancer are already well underway. But to achieve these aims, we need to increase our investment in research.

“We’re calling on the nation to sign up to a March for Men this summer to help raise the funds we desperately need to stop prostate cancer being a killer.”